combinations of cabozantinib and atezolizumab to treat cancer

• 收藏
• 分享

专利权人:

INC.;EXELIXIS

发明人:

CHRISTIAN SCHEFFOLD,COLIN HESSEL,GISELA SCHWAB

申请号：

BR112019015011

公开号：

BR112019015011A2

申请日:

2018.01.19

申请国别(地区):

BR

年份:

2020

代理人:

摘要：

this invention relates to the combination of cabozantinib and atezolizumab to treat solid metastatic or locally advanced tumors, particularly, advanced urothelial cancer or renal cell carcinoma.esta invenção se refere à combinação de cabozantinibe e atezolizumabe para tratar tumores sólidos metastáticos ou localmente avançados, particularmente, câncer urotelial avançado ou carcinoma celular renal.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/